Our Opinion

Eledon Pharmaceuticals Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“There is strong scientific rationale for this indication, as blocking CD40 ligand has been shown in preclinical studies to slow disease progression and improve renal function in animal models of autoimmune nephritis. We look forward to initiating a Phase 2 trial for this fourth indication in the coming months.” Read the following article

Company Description

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing medicines for persons living with an autoimmune disease, which requires an organ or cell-based transplant or living with amyotrophic lateral sclerosis (ALS). The Company’s lead product candidate, AT-1501, is a humanized monoclonal antibody (mAb) designed to target CD40 Ligand (CD40L) also called CD154), a molecule expressed on the surface of human immune system T cells.

Company Website: https://eledon.com